Cemdisiran, Dosed Subcutaneously Every 12 Weeks, Demonstrates Rapid, Deep and Sustained Disease Control in Generalized Myasthenia Gravis (gMG) Phase 3 Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. GOOGL
5. APGE
6. MU
7. DFTX
8. LLY
9. RGNX
10. LCO

Go back to Cemdisiran, Dosed Subcutaneously Every 12 Weeks, Demonstrates Rapid, Deep and Sustained Disease Control in Generalized Myasthenia Gravis (gMG) Phase 3 Trial
Regeneron (NASDAQ: REGN) Delayed: 607.46 -2.48 (0.41%)
Previous Close $609.94    52 Week High $592.36 
Open $604.46    52 Week Low $325.35 
Day High $612.70    P/E 159.44 
Day Low $594.90    EPS $3.81 
Volume 461,018       

Regeneron (NASDAQ: REGN) Delayed: 607.46 -2.48 (0.41%)
Previous Close $609.94    52 Week High $592.36 
Open $604.46    52 Week Low $325.35 
Day High $612.70    P/E 159.44 
Day Low $594.90    EPS $3.81 
Volume 461,018